JESSICA RANDOLPH: Open Payments
NPI 1275191074 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 40 payments from 9 companies in 2025. Trend: 2023 $681 · 2024 $717 · 2025 $838
Food & beverage: $738Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| GENZYME CORPORATION | 12 | $147 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Optinose US, Inc. | 4 | $87 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
| Amgen Inc. | 1 | $14 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Rhapsido, Xhance, FASENRA, AIRSUPRA, TEZSPIRE, Sajazir.
Industry payments across OH — which companies pay providers there.
